Clinical trial
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units
NCT00099775 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00099775 |
|---|---|
| Title | Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units |
| Official title | A Randomized Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis |
| Intervention type | Drug |
| Interventions | Caspofungin |
| Enrollment | 1,200 |
| Start date | Dec 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Dec 20, 2004 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: